The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Inositol Stereoisomers Stabilize an Oligomeric Aggregate of Alzheimer Amyloid β Peptide and Inhibit Aβ-induced Toxicity
Open accessAbstract
Inositol has 8 stereoisomers, four of which are physiologically active. myo-Inositol is the most abundant isomer in the brain and more recently shown that epi- and scyllo-inositol are also present. myo-Inositol complexes with Abeta42 in vitro to form a small stable micelle. The ability of inositol stereoisomers to interact with and stabilize small Abeta complexes was addressed. Circular dichroism spectroscopy demonstrated that epi- and scyllo- but not chiro-inositol were able to induce a structural transition from random to beta-structure in Abeta42. Alternatively, none of the stereoisomers were able to induce a structural transition in Abeta40. Electron microscopy demonstrated that inositol stabilizes small aggregates of Abeta42. We demonstrate that inositol-Abeta interactions result in a complex that is non-toxic to nerve growth factor-differentiated PC-12 cells and primary human neuronal cultures. The attenuation of toxicity is the result of Abeta-inositol interaction, as inositol uptake inhibitors had no effect on neuronal survival. The use of inositol stereoisomers allowed us to elucidate an important structure-activity relationship between Abeta and inositol. Inositol stereoisomers are naturally occurring molecules that readily cross the blood-brain barrier and may represent a viable treatment for AD through the complexation of Abeta and attenuation of Abeta neurotoxic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Self-citationGoodman, Y., Bruce, A. J., Cheng, B., & Mattson, M. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66051836.x · Cited by 830
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727
Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain
Gravina, S. A., Ho, L., Eckman, C. B., Long, K. E., Otvos, L., Younkin, L. H., Suzuki, N., & Younkin, S. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7013 · Cited by 676
Roher, A. E., Chaney, M. O., Kuo, Y.-M., Webster, S. D., Stine, W. B., Haverkamp, L. J., Woods, A. S., Cotter, R. J., Tuohy, J. M., Krafft, G. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20631 · Cited by 498
Wang, A., & Bolen, D. W. (1997) · Biochemistry · doi:10.1021/bi970247h · Cited by 451
The toxicity in vitro of β-amyloid protein
Iversen, L. L., Mortishire-Smith, R. J., Pollack, S. J., & Shearman, M. S. (1995) · Biochemical Journal · doi:10.1042/bj3110001 · Cited by 429
Phosphatidic acid, a key intermediate in lipid metabolism
Athenstaedt, K., & Daum, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00822.x · Cited by 403
Lansbury, P. T., Costa, P. R., Griffiths, J. M., Simon, E. J., Auger, M., Halverson, K. J., Kocisko, D. A., Hendsch, Z. S., Ashburn, T. T., Spencer, R. G. S., et al. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb1195-990 · Cited by 396
A detergent-insoluble membrance compartment contains Aβ in vivo
Lee, S.-J., Liyanage, U., Bickel, P. E., Xia, W., Lansbury, P. T., & Kosik, K. S. (1998) · Nature Medicine · doi:10.1038/nm0698-730 · Cited by 395
Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome
Iwatsubo, T., Mann, D. M. A., Odaka, A., Suzuki, N., & Ihara, Y. (1995) · Annals of Neurology · doi:10.1002/ana.410370305 · Cited by 384
Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I., Becker, G. W., & Brems, D. N. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10007-2 · Cited by 371
Kisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G., & Szarek, W. A. (1995) · Nature Medicine · doi:10.1038/nm0295-143 · Cited by 363
Self-citationOda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., et al. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1080 · Cited by 352
McLaurin, J., & Chakrabartty, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26482 · Cited by 335
Self-citationPresence of soluble amyloid β–peptide precedes amyloid plaque formation in Down's syndrome
Teller, J. K., Russo, C., Debusk, L. M., Angelini, G., Zaccheo, D., Dagna-Bricarelli, F., Scartezzini, P., Bertolini, S., Mann, D. M. A., Tabaton, M., et al. (1996) · Nature Medicine · doi:10.1038/nm0196-93 · Cited by 328
Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin
Tomiyama, T., Shoji, A., Kataoka, K.-I., Suwa, Y., Asano, S., Kaneko, H., & Endo, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6839 · Cited by 295
Xia, W., Zhang, J., Kholodenko, D., Citron, M., Podlisny, M. B., Teplow, D. B., Haass, C., Seubert, P., Koo, E. H., & Selkoe, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7977 · Cited by 284
Paradis, E., Douillard, H., Koutroumanis, M., Goodyer, C., & LeBlanc, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-23-07533.1996 · Cited by 282
Specific Domains of β-Amyloid from Alzheimer Plaque Elicit Neuron Killing in Human Microglia
Giulian, D., Haverkamp, L. J., Yu, J. H., Karshin, W., Tom, D., Li, J., Kirkpatrick, J., Kuo, Y.-M., & Roher, A. E. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06021.1996 · Cited by 271
Manipulating the Amyloid-β Aggregation Pathway with Chemical Chaperones
Yang, D.-S., Yip, C. M., Huang, T. H. J., Chakrabartty, A., & Fraser, P. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32970 · Cited by 268
Self-citationMcLaurin, J., Franklin, T., Zhang, X., Deng, J., & Fraser, P. E. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00957.x · Cited by 258
Self-citationCastillo, G. M., Ngo, C., Cummings, J., Wight, T. N., & Snow, A. D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062452.x · Cited by 234
Goodman, Y., & Mattson, M. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020869.x · Cited by 231
Amyloid β peptide induces necrosis rather than apoptosis
Behl, C., Davis, J. B., Klier, F. G., & Schubert, D. (1994) · Brain Research · doi:10.1016/0006-8993(94)91659-4 · Cited by 220
Weiss, J. H., Pike, C. J., & Cotman, C. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010372.x · Cited by 211
Reduced Phosphoinositide Concentrations in Anterior Temporal Cortex of Alzheimer‐Diseased Brains
Stokes, C. E., & Hawthorne, J. N. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05619.x · Cited by 206
McLaurin, J., Franklin, T., Fraser, P. E., & Chakrabartty, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4506 · Cited by 188
Self-citationMann, D. M. A., Iwatsubo, T., Cairns, N. J., Lantos, P. L., Nochlin, D., Sumi, S. M., Bird, T. D., Poorkaj, P., Hardy, J., Hutton, M., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400205 · Cited by 184
Amyloid β protein (Aβ) removal by neuroglial cells in culture
Shaffer, L. M., Dority, M. D., Gupta-Bansal, R., Frederickson, R. C. A., Younkin, S. G., & Brunden, K. R. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00055-j · Cited by 182
The interaction between Alzheimer amyloid β(1–40) peptide and ganglioside GM1‐containing membranes
Choo-Smith, L.-P., & Surewicz, W. K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01504-9 · Cited by 178
Proteoglycan-mediated Inhibition of Aβ Proteolysis
Gupta-Bansal, R., Frederickson, R. C. A., & Brunden, K. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18666 · Cited by 176
Giulian, D., Haverkamp, L. J., Yu, J., Karshin, W., Tom, D., Li, J., Kazanskaia, A., Kirkpatrick, J., & Roher, A. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29719 · Cited by 164
Phosphatidylinositol and inositol involvement in alzheimer amyloid-β fibril growth and arrest
McLaurin, J., Franklin, T., Chakrabartty, A., & Fraser, P. E. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1677 · Cited by 161
Self-citationBouillot, C., Prochiantz, A., Rougon, G. N., & Allinquant, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7640 · Cited by 137
Du, Y., Bales, K. R., Dodel, R. C., Liu, X. F., Glinn, M. A., Horn, J. W., Little, S. P., & Paul, S. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70031182.x · Cited by 114
Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) Neurotoxicity
Boggs, L. N., Fuson, K. S., Baez, M., Churgay, L. M., McClure, D. B., Becker, G., & May, P. C. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031324.x · Cited by 108
Amyloid β protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid β protein
Ueda, K., Fukui, Y., & Kageyama, H. (1994) · Brain Research · doi:10.1016/0006-8993(94)91736-1 · Cited by 102
Identification of scyllo‐inositol in proton NMR spectra of human brain in vivo
Michaelis, T., Helms, G., Merboldt, K., Hänicke, W., Bruhn, H., & Frahm, J. (1993) · NMR in Biomedicine · doi:10.1002/nbm.1940060116 · Cited by 100
Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β-amyloid in rat PC12 cells
Pollack, S. J., Sadler, I. I. J., Hawtin, S. R., Tailor, V. J., & Shearman, M. S. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11182-i · Cited by 98
The length of Amyloid-β in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type
Castaño, E. M., Prelli, F., Soto, C. A., Beavis, R. C., Matsubara, E., Shoji, M., & Frangione, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32185 · Cited by 91
Role of Increased Cerebral myo‐Inositol in the Dementia of Down Syndrome
Shonk, T., & Ross, B. D. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910330619 · Cited by 88
Effect of tumor necrosis factor α and β on human oligodendrocytes and neurons in culture
McLaurin, J., DSouza, S., Stewart, J., Blain, M., Beaudet, A., Nalbantoglu, J. N., & Antel, J. P. (1995) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(95)00012-6 · Cited by 74
Self-citationNa+‐Dependent and Phlorizin‐Inhibitable Transport of Glucose and Cycasin in Brain Endothelial Cells
Matsuoka, T., Nishizaki, T., & Kisby, G. E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020772.x · Cited by 30
Down's syndrome fibroblasts exhibit enhanced inositol uptake
Fruen, B. R., & Lester, B. R. (1990) · Biochemical Journal · doi:10.1042/bj2700119 · Cited by 28
Evidence that glypican is a receptor mediating β-amyloid neurotoxicity in PC12 cells
Schulz, J. G., Megow, D., Reszka, R. C., Villringer, A., Einhäupl, K. M., & Dirnagl, U. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00220.x · Cited by 18
Klegeris (1997) · doi:10.1002/(sici)1097-4547(19970715)49:2
Ard (1996) · doi:10.1002/(sici)1097-4547(19960115)43:2
Cited by
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Emmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., Stefanis, L., & Vekrellis, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5699-09.2010 · Cited by 1,115
“It has been hypothesized that SI could stabilize a nontoxic oligomeric conformation preventing the production of the more toxic protofibrils (McLaurin et al., 2000; Townsend et al., 2006).”
BackgroundThe Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
Natural product and natural product derived drugs in clinical trials
Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00064a · Cited by 602
Metadata
- Authors
- McLaurin, J., Golomb, R., Jurewicz, A., Antel, J. P., & Fraser, P. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 275
- Issue
- 24
- Pages
- 18495-18502
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2074666700
- Cited by
- 266
- References
- 57
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.